Join
Live feed
·
PRReleasevia Quantisnow
BioCryst Pharmaceuticals Inc. logo

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

ByQuantisnow·Wall Street's wire, on your screen.
BCRX· BioCryst Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.